Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia? | Blood;136(19): 2233-2235, 2020 11 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia?

Gaynon, Paul S; Orgel, Etan; Ji, Lingyun.

Affiliation

Gaynon PS; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA; and.
Orgel E; Keck School of Medicine and.
Ji L; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA; and.

Blood ; 136(19): 2233-2235, 2020 11 05.

Article in En | MEDLINE | ID: mdl-32603411

Subject(s)

Precursor Cell Lymphoblastic Leukemia-Lymphoma; Genomics; Humans; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Blood Year: 2020 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Blood Year: 2020 Type: Article